期刊档案

Asian Pacific Journal of Cancer Prevention

— · ISSN 1513-7368 · 医学-肿瘤学

数据可追溯 · letpub-v6 · 更新于 2026-08-25
影响指标
h-index65
平均审稿速度网友分享经验:平均3.0个月
平均录用比例网友分享经验:约63.57%

期刊简介

研究范围与定位

Cancer is a very complex disease. While many aspects of carcinoge-nesis and oncogenesis are known, cancer control and prevention at the community level is however still in its infancy. Much more work needs to be done and many more steps need to be taken before effective strategies are developed. The multidisciplinary approaches and efforts to understand and control cancer in an effective and efficient manner, require highly trained scientists in all branches of the cancer sciences, from cellular and molecular aspects to patient care and palliation.The Asia Pacific Organization for Cancer Prevention (APOCP) and its official publication, the Asia Pacific Journal of Cancer Prevention (APJCP), have served the community of cancer scientists very well and intends to continue to serve in this capacity to the best of its abilities. One of the objectives of the APOCP is to provide all relevant and current scientific information on the whole spectrum of cancer sciences. They aim to do this by providing a forum for communication and propagation of original and innovative research findings that have relevance to understanding the etiology, progression, treatment, and survival of patients, through their journal. The APJCP with its distinguished, diverse, and Asia-wide team of editors, reviewers, and readers, ensure the highest standards of research communication within the cancer sciences community across Asia as well as globally. The APJCP publishes original research results under the following categories:-Epidemiology, detection and screening.-Cellular research and bio-markers.-Identification of bio-targets and agents with novel mechanisms of action.-Optimal clinical use of existing anti-cancer agents, including combination therapies.-Radiation and surgery.-Palliative care.-Patient adherence, quality of life, satisfaction.-Health economic evaluations.

结构化分区

学科分区明细

不同版本、大类与小类分别展示,不将不同评价口径合并为一个分区值。

《新锐期刊分区表》( 2026年3月发布)

2026-03 · 未被该版本收录

Top:N/A综述:N/A

该期刊未被此版本分区表收录。

期刊分区表( 2025年3月升级版)

2025-03 · 未被该版本收录

Top:N/A综述:N/A

该期刊未被此版本分区表收录。

期刊分区表( 2023年12月旧的升级版)

2023-12 · 未被该版本收录

Top:N/A综述:N/A

该期刊未被此版本分区表收录。

期刊档案

出版与身份

期刊ISSN
1513-7368
E-ISSN
2476-762X
是否OA开放访问
Yes
通讯方式
ASIAN PACIFIC ORGANIZATION CANCER PREVENTION, 4-84 JOTO-CHO, KITA-KU, NAGOYA, JAPAN, 462-0831
出版商
Asian Pacific Organization for Cancer Prevention
出版国家或地区
JAPAN
出版语言
English
出版周期
Quarterly
出版年份
2000

期刊档案

研究范围

期刊简介
Cancer is a very complex disease. While many aspects of carcinoge-nesis and oncogenesis are known, cancer control and prevention at the community level is however still in its infancy. Much more work needs to be done and many more steps need to be taken before effective strategies are developed. The multidisciplinary approaches and efforts to understand and control cancer in an effective and efficient manner, require highly trained scientists in all branches of the cancer sciences, from cellular and molecular aspects to patient care and palliation.The Asia Pacific Organization for Cancer Prevention (APOCP) and its official publication, the Asia Pacific Journal of Cancer Prevention (APJCP), have served the community of cancer scientists very well and intends to continue to serve in this capacity to the best of its abilities. One of the objectives of the APOCP is to provide all relevant and current scientific information on the whole spectrum of cancer sciences. They aim to do this by providing a forum for communication and propagation of original and innovative research findings that have relevance to understanding the etiology, progression, treatment, and survival of patients, through their journal. The APJCP with its distinguished, diverse, and Asia-wide team of editors, reviewers, and readers, ensure the highest standards of research communication within the cancer sciences community across Asia as well as globally. The APJCP publishes original research results under the following categories:-Epidemiology, detection and screening.-Cellular research and bio-markers.-Identification of bio-targets and agents with novel mechanisms of action.-Optimal clinical use of existing anti-cancer agents, including combination therapies.-Radiation and surgery.-Palliative care.-Patient adherence, quality of life, satisfaction.-Health economic evaluations.
涉及的研究方向
医学-肿瘤学

期刊档案

指标与活跃度

2025-2026最新IF(数据来源于网友提供)
注册或登录后,查看IF
2025-2026自引率
N.A.点击查看自引率趋势图
五年IF(数据来源于网友提供)
0
h-index
65
CiteScore ( 2026年6月最新版)
CiteScoreSJRSNIPCiteScore排名3.100.4980.672学科分区排名百分位大类:Medicine小类:Public Health, Environmental and Occupational HealthQ2333 / 725 54% 大类:Medicine小类:EpidemiologyQ287 / 173 50% 大类:Medicine小类:OncologyQ3258 / 428 39% 大类:Medicine小类:Cancer ResearchQ4176 / 233 24%
年文章数
1385点击查看年文章数趋势图
Gold OA文章占比
0.00%
研究类文章占比:文章 ÷(文章 + 综述)
0.00%

期刊档案

分区、收录与风险

WOS期刊JCR分区 ( 2025-2026年最新版)
注册或登录后,查看WOS分区等级
期刊分区表预警名单
2026年03月发布的新锐学术版:不在预警名单中2025年03月发布的2025版:不在预警名单中2024年02月发布的2024版:不在预警名单中2023年01月发布的2023版:不在预警名单中2021年12月发布的2021版:不在预警名单中2020年12月发布的2020版:不在预警名单中
SCI期刊收录coverage
Scopus (CiteScore)Directory of Open Access Journals (DOAJ)
PubMed Central (PMC)链接
访问官方页面 ↗

期刊档案

投稿与评审

期刊官方网站
访问官方页面 ↗
期刊投稿网址
访问官方页面 ↗
平均审稿速度
网友分享经验:平均3.0个月
平均录用比例
网友分享经验:约63.57%

来源与统计口径

来源:LetPub 原始详情页 ↗。投稿经验仅展示聚合统计,不公开第三方正文或用户标识。当前聚合样本:暂无。